Image Analysis Group (IAG) is a leading imaging CRO using the DYNAMIKA AI platform and expert readers to deliver compliant clinical trials.
Location: United Kingdom
Investors 1
| Date | Name | Website |
| - | Biovision ... | biovision.... |
Mentions in press and media 6
| Date | Title | Description |
| 17.03.2026 | Image Analysis Group Achieves SOC 2 Type II Certification, Setting the Enterprise Benchmark for Global Imaging CROs | Image Analysis Group (IAG) DYNAMIKA™ at IAG DYNAMIKA™ delivers SOC 2 Type II–certified, AI‑driven imaging workflows, giving pharma and biotech secure, compliant oversight of imaging data in global trials. LONDON, UNITED KINGDOM, March 17, 2... |
| 23.02.2026 | Image Analysis Group Expands Executive Leadership Across Quality and Finance | Image Analysis Group (IAG) Jonathan Shaul | CFO | IAG Derek Hunter | Head of Quality | IAG DYNAMIKA™ at IAG New leadership in quality and finance strengthens IAG’s global clinical trial imaging capabilities for biotech and pharma sponsors. ... |
| 05.01.2026 | Image Analysis Group (IAG) and Ferring Pharmaceuticals Enter Validation Phase of AI Imaging Project | Image Analysis Group (IAG) Ferring Pharmaceuticals DYNAMIKA™ at (IAG) Image Analysis Group and Ferring validate AI imaging biomarkers with FCI and Dexeus to optimize conception timing and personalize fertility care. Image-centric AI collabo... |
| 12.10.2022 | Response Prediction in Oncology Clinical Trials, Upcoming Webinar Hosted by Xtalks | With artificial intelligence (AI) and technology, the relationship between tumour changes and tumour assessment endpoints (ORR, PFS etc.) can be modelled to enhance understanding of the drug mechanism of action in clinical oncology studies.... |
| 05.05.2021 | AI and Cloud – Power of Modern Trial Infrastructure for Accelerated Drug Development, Upcoming Webinar presented by IAG, Image Analysis Group, Hosted by Xtalks | Therapeutic experts will show case studies of early drug evidence, trial enrichment and advanced treatment efficacy assessments from phase I-IV trials in oncology, neurology, and rheumatology. TORONTO (PRWEB) May 05, 2021 Speed, quality, an... |
| 30.03.2021 | The Potential of Advanced Imaging to Show the Early Treatment Effects of Berubicin in Brain Cancer, Upcoming Webinar Hosted by Xtalks | Pseudo-progression is difficult to distinguish from disease progression using routine clinical radiographic assessments. This is where non-invasive methods are needed to enhance the understanding of complex neuro-pathologies. TORONTO (PRWEB... |